Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGRHKJF 77 Return-on-Tangible-Equity is 4.37% as of Mar. 2026, which is 17% above its 10-year median of 3.73. GuruFocus rates RHKJF with a GF Score™ of 77/100 and a GF Value™ of $15.83. The stock has 3 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 67.01% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Rhoen Klinikum AG's annualized net income for the quarter that ended in Mar. 2026 was $59 Mil. Rhoen Klinikum AG's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $1,344 Mil. Therefore, Rhoen Klinikum AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 4.37%.
The historical rank and industry rank for Rhoen Klinikum AG's Return-on-Tangible-Equity or its related term are showing as below:
RHKJF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 0.15 Med: 3.73 Max: 6.14
Current: 3.51
During the past 13 years, Rhoen Klinikum AG's highest Return-on-Tangible-Equity was 6.14%. The lowest was 0.15%. And the median was 3.73%.
RHKJF's Return-on-Tangible-Equity is ranked worse than 67.01% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs RHKJF: 3.51
Rhoen Klinikum AG (OTCPK:RHKJF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Rhoen Klinikum AG Return-on-Tangible-Equity Related Terms
Rhoen Klinikum AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RHKJF vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.37% mean?
Rhoen Klinikum AG (RHKJF) has a Return-on-Tangible-Equity of 4.37% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rhoen Klinikum AG and its competitors. This is 17% above median its historical median of 3.73. Over the past decade, Rhoen Klinikum AG's Return-on-Tangible-Equity has ranged from 0.15 to 6.14. According to the industry distribution chart, Rhoen Klinikum AG ranks #386 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 67%.
Is Rhoen Klinikum AG's Return-on-Tangible-Equity too high?
Rhoen Klinikum AG's current Return-on-Tangible-Equity of 4.37% is 17% above median its 10-year median of 3.73. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 6.14. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Rhoen Klinikum AG's value of 4.37% is 57% below this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #386 out of 576 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #386 out of 576 companies for Return-on-Tangible-Equity. This places Rhoen Klinikum AG in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.17. Rhoen Klinikum AG's value of 4.37% is 57% below this benchmark. Historically, Rhoen Klinikum AG's own Return-on-Tangible-Equity has ranged from 0.15 to 6.14 over the past decade. While the company's 10-year median is 3.73 vs. the industry median of 10.17, Rhoen Klinikum AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current Return-on-Tangible-Equity of 4.37% is 57% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current Return-on-Tangible-Equity is 4.37%, which is 17% above median its own 10-year median of 3.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (RHKJF) has a current Return-on-Tangible-Equity of 4.37%. The stock's GF Value™ is $15.83, compared to a current price of $15.30 — trading 3.3% below its estimated fair value. The current Return-on-Tangible-Equity is 4.37%, which is 17% above median its 10-year median of 3.73 and 57% below the Healthcare Providers & Services industry median of 10.17. Rhoen Klinikum AG's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Rhoen Klinikum AG (RHKJF), the current Return-on-Tangible-Equity is 4.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (RHKJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of $15.30 is trading 3.3% below its estimated GF Value™ of $15.83.
Key valuation signals for RHKJF:
Return-on-Tangible-Equity: 4.37% (17% above median its 10-year median of 3.73)
GF Value™: $15.83 vs. price of $15.30 (3.3% below fair value)
Industry Position: 57% below the Healthcare Providers & Services median (#386 of 576)
No single metric tells the full story. See the RHKJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
77GF Score
Get the complete analysis for RHKJF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RHKJF has been successfully added to your 
